Image

Microbiome in Head and Neck Squamous Cell Carcinoma

Microbiome in Head and Neck Squamous Cell Carcinoma

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.

Description

HNSCCis a lethal cancer with a 5-year survival rate below 50%. Although smoking, alcohol intake, and human papillomavirus (HPV) infection are linked to HNSCC, only a small proportion of individuals exposed to these factors develop cancer and not all cases progress. Thus, additional environmental or host factors must contribute to HNSCC. The Study Team and others have observed significant oral dysbiosis in human HNSCC cases, both before and after treatment. This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.

Eligibility

Inclusion Criteria:

  1. Subjects equal to or above the age of 18.
  2. Patients who are seen and evaluated by a provider within the adult Otolaryngology clinic at the University of Colorado Health.
  3. Patients that present with a diagnosis of OSCC.
  4. An equal number of age-matched patients who are visiting the clinic for reasons other than OSCC diagnoses, as the control group.
  5. Ability to understand and willingness to sign a written informed consent document

Exclusion Criteria:

  1. Subjects under the age of 18 or over the age of 100
  2. Subjects unwilling to particiapte

Study details
    Head and Neck Cancer
    Lip Cancer
    Oral Cancer
    Pharynx Cancer

NCT05837221

University of Colorado, Denver

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.